DUOPHARMA BIOTECH BERHAD Q2 2025 Latest Quarterly Report Analysis
Duopharma Biotech’s Q2 2025 Report: Strong Profit Growth and a Dividend Boost for Shareholders Duopharma Biotech Berhad, a leading name in Malaysia’s pharmaceutical industry, has just released its financial results for the second quarter ending June 30, 2025. The report reveals a story of robust profit growth and strengthening financial health, culminating in a higher…
